ARR3

ARR3 encodes cone arrestin, a visual arrestin expressed in the outer segments of red/green cone photoreceptors that is required for normal cone phototransduction (PMID:41493082, PMID:39420435). Loss-of-function mutations—including nonsense, splicing, and frameshift variants—cause premature termination and nonsense-mediated mRNA decay, abolishing ARR3 protein production (PMID:34966409, PMID:38517428). Heterozygous loss-of-function variants in ARR3 cause X-linked female-limited early-onset high myopia (Myopia-26) through an X-chromosome inactivation mechanism that generates a mosaic retina in which ARR3-null and ARR3-expressing cones coexist, disrupting cone subtype composition, Pde6h expression, and phototransduction signaling (PMID:27829781, PMID:36769483, PMID:41493082). ARR3 mutation carriers exhibit cone-specific electrophysiological dysfunction independent of axial elongation, confirming a primary role in cone photoreceptor signaling (PMID:39420435).

1. 2016 High

   The genetic basis of an unusual female-limited high myopia was unknown; linkage and exome sequencing in three families demonstrated that heterozygous loss-of-function ARR3 variants co-segregate with early-onset high myopia exclusively in females, establishing ARR3 as a disease gene with X-linked female-limited inheritance.

   Evidence Genome-wide linkage scan, whole exome sequencing, Sanger sequencing, and co-segregation analysis across three independent families

   PMID:27829781

   Open questions at the time

   • Mechanism by which ARR3 loss leads to myopia rather than retinal degeneration was unknown
   • Why hemizygous males are unaffected was unexplained
   • No functional assay of variant pathogenicity was performed
2. 2021 Medium

   It was unclear whether ARR3 missense/truncating variants actually eliminate protein; demonstration that a nonsense ARR3 variant triggers nonsense-mediated mRNA decay established that complete loss of ARR3 protein is the pathogenic mechanism.

   Evidence Exome sequencing and functional NMD assay of c.569C>G (p.S190*) transcript in patient cells

   PMID:34966409

   Open questions at the time

   • NMD demonstrated for a single variant; generalizability to other mutation classes not yet shown
   • No animal model to confirm loss-of-function consequences on cone physiology
3. 2023 Medium

   The paradox of female-limited disease from an X-linked gene was resolved when X-chromosome inactivation assays showed that heterozygous females have mosaic retinas with patches of mutant and wild-type ARR3-expressing cones, and skewed XCI correlated with phenotypic severity.

   Evidence X-chromosome inactivation analysis and phenotypic correlation in a family carrying a frameshift ARR3 variant

   PMID:36769483

   Open questions at the time

   • Mosaic retinal pattern not directly visualized at cellular resolution in human tissue
   • Mechanism linking mosaicism to myopia signaling remained speculative
4. 2024 High

   Expanding the mutational spectrum, minigene assays demonstrated that ARR3 splicing variants introduce premature termination codons, confirming that disruption of mRNA processing is another pathogenic mechanism and broadening the class of disease-causing alleles.

   Evidence Minigene splicing assay for two novel ARR3 intronic variants (c.39+1G>A and c.100+4A>G)

   PMID:38517428

   Open questions at the time

   • Endogenous splicing consequences in cone photoreceptors not verified
   • Quantitative effect on ARR3 protein levels not measured
5. 2024 Medium

   Whether ARR3 mutations impair cone function directly—or myopia-associated elongation secondarily degrades cones—was resolved by ERG studies showing cone dysfunction (35% reduced a/b-wave, 55% reduced flicker) specific to ARR3 carriers versus myopes with intact ARR3, establishing a primary cone signaling deficit.

   Evidence Full-field electroretinography in genetically stratified ARR3-mutation carriers versus ARR3-intact high myopes

   PMID:39420435

   Open questions at the time

   • Single-center study; independent replication in larger cohorts needed
   • Which step in cone phototransduction is specifically disrupted remains unresolved
6. 2026 High

   The cellular and molecular consequences of mosaic ARR3 loss were defined: ARR3 localizes to outer segments of M-cones from P14, and heterozygous loss in mice/rats shifts cone subtype proportions and alters Pde6h expression in M/S cones, suggesting that mosaicism disrupts phototransduction and generates defocus-like signals driving myopia.

   Evidence Developmental expression profiling, immunolocalization, retinal flatmounts in Arr3 knock-in mice and knockout rats, single-cell RNA sequencing

   PMID:41493082

   Open questions at the time

   • Causal link between cone mosaicism and axial elongation signaling not directly demonstrated
   • Downstream retinal signaling pathway translating phototransduction disruption into scleral growth not identified
   • Whether S-cone enrichment itself contributes to myopia signals is untested

• The mechanism by which mosaic cone phototransduction disruption is transduced into scleral remodeling and axial elongation—the ultimate cause of myopia—remains unknown.
• No identification of retina-to-sclera signaling intermediates downstream of ARR3-dependent cone mosaicism
• No structural model of ARR3 interaction with cone opsins
• No therapeutic rescue experiments in animal models